The role of C-reactive protein as a cardiovascular risk predictor
Journal Title: Kardiochirurgia i Torakochirurgia Polska - Year 2006, Vol 3, Issue 1
Abstract
A wealth of evidence supports the concept of inflammation playing a pivotal role in the development and progression of atherosclerosis. C-reactive protein (CRP) is a sensitive acute-phase inflammatory marker for the development of cardiovascular events such as coronary artery disease, myocardial infarction and stroke. Numerous studies indicate that CRP is not only a biomarker but also an active mediator of inflammation and atherogenesis through its direct effects on leukocytes and endothelial cells. We review the evidence and suggest mechanisms by which CRP can affect arterial endothelial cell activation, macrophage recruitment and foam cell generation and the development of atherosclerotic lesions. We emphasize the direct role of CRP in sustaining a proinflammatory and procoagulant milieu within the arterial neointima. This review also proposes that CRP can directly injure arterial endothelium and is a molecule involved in the maintenance of a systemic proatherosclerotic environment. In addition, we review therapies that target CRP for both the prevention and treatment of atherosclerotic diseases.
Authors and Affiliations
George Boguslawski
Tissue engineering methods as a potential instrument used in treatment of circulatory system diseases
Tissue engineering as well as the cell culture techniques seem to be the promising perspective of alternative treatment of circulatory system diseases. Quite recently, mentioned methods have been still only in the phase...
Transcatheter closure of atrial septal defects - own experience after 502 procedures
Introduction: Percutaneous closure has became treatment of choice in selected cases of atrial septal defects type II (ASD). Aim: To show own experience in this field. Material and methods: Between 1997-2005 there were...
What is “normal” pump flow?
Postdoctorial Research Fellowship – inny pacjent, ta sama medycyna
Heparin induced thrombocytopenia as a complication of coronary artery by-pass surgery - case report
A 67-year-old woman with ischemic cardiomyopathy (EF=32%) was scheduled for elective coronary artery by-pass grafting surgery. The operation was performed on the beating heart (OPCAB). In the early postoperative period t...